Our in vitro experiments further emphasize the clinical importance of GFPT1, as silencing its expression significantly impaired breast cancer cell viability, migration, and survival, while GFPT1 overexpression enhanced these properties. This evidence concerns the gene GFPT1 and breast cancer.